Managing Epilepsy Well
(SIP 12-056); Nancy Thompson, PI http://www.sph.emory.edu/faculty/profile/#NTHOMPS
The Managing Epilepsy Well (MEW) network is a thematic research network designed to address gaps in knowledge and programs related to improving epilepsy self-management and quality of life for people with epilepsy. It is comprised of six collaborating centers: Emory University, University of Michigan, University of Texas Health Science Center at Houston, University of Washington, Dartmouth College and Case Western Reserve University. The mission of the MEW Network is to advance the science related to epilepsy self-management by facilitating and implementing research, conducting research in collaboration with network members and community stakeholders, and broadly disseminating research findings.
Emory conducts research related to epilepsy self-management, to depression prevention and treatment among people with epilepsy, and to the distance-delivery of self-management programs to people with epilepsy. Emory is currently engaged in the dissemination of WebEase (an on-line epilepsy self-management program) and of Project UPLIFT (a home-based intervention delivered by phone or on the Internet to prevent or treat depression among people with epilepsy).
For more information visit the Managing Epilepsy Well Network websitehttp://www.sph.emory.edu/ManagingEpilepsyWell/.
Intervention Research on Home-based Depression Treatment in People with Epilepsy
(SIP 7-2006); Nancy Thompson, PI http://www.sph.emory.edu/faculty/profile/#NTHOMPS
This project involved developing and pilot testing effectiveness of a small-group Mindfulness-Based Cognitive Therapy (MBCT) phone or internet delivered program to reduce depression in people with epilepsy.
Use of Computer Multimedia Technology to Develop a Theory-Driven, Interactive Chronic Disease Self-management Program (WebEase)
(SIP 2-2005); Colleen DiIorio, PI (no link)
This multi-phase project developed and pilot tested a Web-based, theory-driven self-management intervention for older adolescents and adults with epilepsy.